Daobin Zhou

24PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 28, 2026
Baseline Monoclonal Protein Identifies Plasmacytic Differentiation and Shorter Progression-Free Survival in Marginal Zone Lymphoma.

|Oct 20, 2026
A multicentre phase III clinical trial of dual-epigenetic therapy plus CHOP compared with CHOP in previously untreated patients with peripheral T-cell lymphoma.

|Apr 24, 2026
UNC13D in Familial Hemophagocytic Lymphohistiocytosis and Beyond: Functional Mechanisms, Genetic Variants, Multisystem Disease Spectrum and Clinical Implications.

|Feb 11, 2026
Clonal haematopoiesis in T-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution.

Chong Wei, Yan Zhang, Danqing Zhao

|Jun 24, 2025
Germline defects of familial haemophagocytic lymphohistiocytosis-Related genes may represent a predisposing factor for mature T- and natural killer-cell lymphoma.

Chong Wei, Yan Zhang, Danqing Zhao

|Nov 08, 2024
BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

Min Lang, Long Chang, Hao Cai

Pageof 4

Frequent Collaborators

10 joint publications

Xin-Xin Cao

10 joint publications

Wei Zhang

9 joint publications

Jian Li

7 joint publications

Ming-Hui Duan